N-(2-pyridinylmethyl)cyclohexanamine dihydrobromide, 95.0%, 1g

((2R,7aR)-2-Fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methanol, 97%, 500mg

5,8-Dioxa-2-azaspiro[3.4]octane hydrochloride, 97%, 10g

1-Bromo-2-methoxy-4-phenylmethoxybenzene, 97%, 5g

2-hydroxy-3-(3-methoxyphenyl)prop-2-enoic acid, 95%, 1g

2,3,4-Trimethoxybenzonitrile, 95+%, 5g

2,6-Dichlorophenol>99.0%(GC)500g

1-PIPERIDINECARBONYL CHLORIDE, 95.0%, 10g

Coumarin>99.0%(GC)25g

4-Methyl-6-methylsulfanyl-nicotinic acid, 95+%, 1g

GC capillary column ROTI®Cap-1701, 50 m, 0.32 mm, 1.00 µm, 1 Piece(s)

7-Chloroquinazolin-4-ol, 95.0%, 25g

1-(4,5-Dihydro-1H-1,5-methanobenzo[d]azepin-3(2H)-yl)-2,2,2-trifluoroethanone, 95.0%, 10g